IL11 and ovarian cancer: Our results indicate that EGCG, I3C, and Pano significantly downregulate levels of the protumorigenic cytokine IL-11, which is a major factor implicated in the chemoresistance of ovarian cancer cells through the activation of the JAK2-STAT5 pathway [62].